Prelude Capital Management’s Exponent EXPO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-3,133
Closed -$259K – 1305
2024
Q1
$259K Buy
+3,133
New +$259K 0.01% 963
2023
Q3
– Sell
-3,281
Closed -$306K – 1202
2023
Q2
$306K Sell
3,281
-313
-9% -$29.4K 0.02% 635
2023
Q1
$358K Buy
+3,594
New +$366K 0.02% 582
2022
Q4
– Sell
-4,441
Closed -$389K – 1416
2022
Q3
$389K Buy
4,441
+2,061
+87% +$195K 0.01% 757
2022
Q2
$218K Buy
+2,380
New +$224K 0.01% 1252
2022
Q1
– Sell
-2,140
Closed -$250K – 1957
2021
Q4
$250K Buy
2,140
+209
+11% +$24.6K 0.01% 1434
2021
Q3
$218K Buy
+1,931
New +$208K 0.01% 1312
2021
Q1
– Sell
-3,425
Closed -$308K – 1632
2020
Q4
$308K Buy
+3,425
New +$273K 0.01% 907
2015
Q2
– Sell
-2,000
Closed -$44K – 1791
2015
Q1
$44K Buy
2,000
+912
+84% +$19.5K 0.01% 1363
2014
Q4
$22K Buy
+1,088
New +$21.1K ﹤0.01% 1713
2014
Q2
– Sell
-2,000
Closed -$38K – 1989
2014
Q1
$38K Sell
2,000
-4,348
-68% -$80.2K 0.01% 1403
2013
Q4
$123K Buy
6,348
+4,348
+217% +$82.1K 0.02% 788
2013
Q3
$36K Buy
+2,000
New +$33.3K 0.01% 1007

Other funds holding EXPO

Prelude Capital Management's EXPO Position: Q2 2024 in Review

Prelude Capital Management sold out of Exponent (EXPO) in Q2 2024, closing a stake of 3,133 shares — an estimated $259K sold.

Prelude Capital Management first reported a position in EXPO in Q3 2013 and held it in 13 quarters. The position peaked at $389K in Q3 2022. 354 funds tracked by Wall St. Rank hold EXPO as of Q2 2024.

  • Prelude Capital Management reported no remaining Exponent position as of Q2 2024 after selling out during the quarter.
  • Prelude Capital Management sold 3,133 Exponent shares in Q2 2024, an estimated $259K.
  • Prelude Capital Management first reported a position in Exponent in Q3 2013 and held it in 13 quarters.
  • Prelude Capital Management's Exponent position peaked at $389K in Q3 2022.
  • 354 funds tracked by Wall St. Rank held Exponent as of Q2 2024.

Based on Prelude Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.